Skip to main content
Year archive

Vicore Pharma Holding — 2023 filings

All 35 regulatory filings released by Vicore Pharma Holding (VICO) in 2023, sourced directly from the official regulator.

35 Filings
2023 Period
2023 filings (35)
Filing Released Lang
Interim / Quarterly Report 2023
Interim / Quarterly Report 9M 2023
2023-11-02 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q3 2023
2023-11-02 English
Vicore announces the Nomination Committee for the 2024 Annual General Meeting
Board/Management Information
2023-10-31 English
Vicore offentliggör valberedningen inför årsstämman 2024
Board/Management Information
2023-10-31 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q2 2023
2023-08-24 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q2 2023
2023-08-24 English
Ökning av antalet aktier och röster i Vicore Pharma
Declaration of Voting Results & Voting Rights Announcements
2023-07-31 Swedish
Increase of number of shares and votes in Vicore Pharma
Share Issue/Capital Change
2023-07-31 English
Vicore announces the appointment of Ahmed Mousa as CEO
Board/Management Information
2023-07-13 English
Vicore utser Ahmed Mousa till ny VD
Board/Management Information
2023-07-13 Swedish
Vicore Pharma publishes a prospectus for admission to trading of shares on Nasdaq Stockholm
Share Issue/Capital Change
2023-07-07 English
Vicore Pharma offentliggör prospekt för upptagande till handel av aktier på Nasdaq Stockholm
Share Issue/Capital Change
2023-07-07 Swedish
Vicore offentliggör VD-rekryteringsprocess
Board/Management Information
2023-07-05 Swedish
Vicore announces CEO recruitment process
Board/Management Information
2023-07-05 English
Bulletin from the extraordinary general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2023-07-05 English
Kommuniké från extra bolagsstämma i Vicore Pharma Holding AB (publ)
Share Issue/Capital Change
2023-07-05 Swedish
Major Shareholding Notification 2023
Major Shareholding Notification
2023-06-30 English
Ökning av antalet aktier och röster i Vicore Pharma
Share Issue/Capital Change
2023-06-30 Swedish
Increase of number of shares and votes in Vicore Pharma
Share Issue/Capital Change
2023-06-30 English
Kallelse till extra bolagsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2023-06-09 Swedish
Notice of extraordinary general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2023-06-09 English
Vicore has carried out directed share issuances of in total 29,875,000 shares at a subscription price of SEK 16.75 per share, raising gross proceeds of SEK 500 million
Capital/Financing Update
2023-06-09 English
Vicore har genomfört riktade nyemissioner av totalt 29 875 000 aktier till en teckningskurs om 16,75 kronor per aktie och tillförs en bruttolikvid om 500 miljoner kronor
Capital/Financing Update
2023-06-09 Swedish
Vicore avser att genomföra riktade nyemissioner av aktier
Share Issue/Capital Change
2023-06-08 Swedish
Vicore intends to carry out directed share issuances
Capital/Financing Update
2023-06-08 English
Kommuniké från årsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2023-05-11 Swedish
Bulletin from the annual general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2023-05-11 English
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-04 Swedish
Interim / Quarterly Report 2023
Interim / Quarterly Report Q1 2023
2023-05-04 English
Kallelse till årsstämma i Vicore Pharma Holding AB (publ)
AGM Information
2023-04-05 Swedish
Notice of annual general meeting of Vicore Pharma Holding AB (publ)
AGM Information
2023-04-05 English
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-04-05 Swedish
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-04-05 English
Earnings Release 2022
Earnings Release Q4 2022
2023-02-28 Swedish
Interim / Quarterly Report 2022
Interim / Quarterly Report FY 2022
2023-02-28 English